KLK3 and prostate carcinoma: In a clinical trial of 6,630 men, Catalona et al. showed that combination of PSA ≥ 4.0 ng/mL with other clinical findings, such as those from digital rectal examination (DRE), improved the detection of prostate cancer detection [26].